Differential expression analysis for paired RNA-seq data
- Lisa M Chung^{1}Email author,
- John P Ferguson^{2},
- Wei Zheng^{3},
- Feng Qian^{4},
- Vincent Bruno^{5},
- Ruth R Montgomery^{4} and
- Hongyu Zhao^{1}Email author
DOI: 10.1186/1471-2105-14-110
© Chung et al.; licensee BioMed Central Ltd. 2013
Received: 16 October 2012
Accepted: 1 March 2013
Published: 27 March 2013
Abstract
Background
RNA-Seq technology measures the transcript abundance by generating sequence reads and counting their frequencies across different biological conditions. To identify differentially expressed genes between two conditions, it is important to consider the experimental design as well as the distributional property of the data. In many RNA-Seq studies, the expression data are obtained as multiple pairs, e.g., pre- vs. post-treatment samples from the same individual. We seek to incorporate paired structure into analysis.
Results
We present a Bayesian hierarchical mixture model for RNA-Seq data to separately account for the variability within and between individuals from a paired data structure. The method assumes a Poisson distribution for the data mixed with a gamma distribution to account variability between pairs. The effect of differential expression is modeled by two-component mixture model. The performance of this approach is examined by simulated and real data.
Conclusions
In this setting, our proposed model provides higher sensitivity than existing methods to detect differential expression. Application to real RNA-Seq data demonstrates the usefulness of this method for detecting expression alteration for genes with low average expression levels or shorter transcript length.
Background
Gene expression profiles are routinely collected to identify differentially expressed genes and pathways across various individuals and cellular states. Sequencing-based technologies offer more accurate quantification of expression levels compared to other technologies. Early sequence-based expression measured transcript abundance by counting short segments, known as tags, generated from the 3’ end of a transcript. Tag-based methods include the Serial Analysis of Gene Expression (SAGE, [1]), Cap Analysis of Gene Expression (CAGE), LongSAGE, and massively parallel signature sequencing (MPSS). The development of deep sequencing technology enables simultaneous sequencing of millions of molecules and has led to advanced approaches for expression measurement [2, 3]. Digital gene expression - tag profiling [4] adapted the tag-based approach for use with the ‘next-generation’ sequencing platform. RNA-Seq is an alternative approach, that is an application of ‘whole genome shotgun sequencing’. Briefly, it entails generating a cDNA library by random priming off of fragmented RNA. The cDNA library is then subject to next-generation sequencing to generate short nucleotide sequences (reads) that correspond to the ends of the cDNA fragments. RNA-Seq aims to measure the entire transcriptome and is preferable to microarrays and tag-based approaches since it provides more information such as alternative splicing and isoform-specific gene expression with very low background signal and a wider dynamic range of quantification [5]. Moreover, recent experiments revealed that the RNA-Seq measures expression level with high accuracy and reproducibility [6-9].
Sequence-based approaches quantify gene expression as a ‘digital’ count and require modeling suitable for a count random variable. The Poisson distribution has been central in modelling expression data [10-12] and commonly applied to RNA-Seq data [6, 13]. In particular, Li et al. (2012) proposed a permutation-based approach to generate the null distribution [14]. However, Poisson-based approaches may not take all the variations between biological samples into account. The Beta-Binomial hierarchical model [15, 16], overdispersed logistic [17], and overdispersed log-linear models [18] were proposed to capture extra variance for each gene separately. Negative Bionomial models have been proposed to estimate the overdispersion parameter by shrinkage estimation [19-21], mean-dependent local regression [22], or empirically derived prior distribution [23]. Alternatively, beta-binomial [24] and Poisson mixture [25] models were proposed under the Bayesian modeling framework. Nonparametric method with resampling was also considered [26]. These approaches generally assume that samples under two groups are obtained independently. Recently, some of these approaches have been extended to deal with multi-factor design structures [14, 16, 21, 22].
Many practical RNA sequencing studies collect data with a paired structure, where the global expression profiles are measured before and after a treatment is applied to the same individual. Appropriate modeling of such data requires taking this design structure as well as the distributional property of the data into account. The Poisson model has been used to test the effect of drugs when the observation occurs as paired data, such as predrug and postdrug counts [27]. Lee [28] considered a mixture model to account for extra variance among individuals over the level that would be expected under the Poisson model. These approaches assume independence of the paired observation conditional on the individual mean. Bivariate Poisson or negative binomial distribution are alternative choices to model correlations between observations [29, 30].
In this paper, we propose a Bayesian hierarchical approach to modeling paired count data that separately accounts for the within and between individual variability from a paired data structure. Our work adopts the Poisson-Gamma mixture model [28] and utilizes a Bayesian approach to evaluate the expression difference. We note that the Bayesian models are widely utilized in microarray studies and have improved sensitivity to detect differential gene expression by sharing information among genes [31]. Mixture models are also commonly used to model differential expression, where non-differentially expressed and differently expressed genes correspond to different mixture components. Various mixture model specifications have been considered in the literature. The gamma and log-normal distribution were used to model the expression levels [32, 33]. Smyth [34] assumed a point mass at zero for log scaled fold change for null genes and a normal distribution centered at zero for non-null genes. Lonnstedt et al. [35] and Gottardo et al. [36] proposed a mixture of two (null and non-null) or three normal (null, over, and under expression) distributions. Non-parametric approaches have also been utilized [31, 37]. Lewin et al. [38] discussed various choices of mixture component priors and model checking.
The rest of this manuscript is organized as follows. Data Section introduces the biological problem and data that motivated this study. Methods Section presents our parametric model and the Bayesian method to identify genes with differential expression levels. The performance of the proposed model is examined by Simulations. Two sets of simulation studies are conducted: (1) those based on the model assumption to investigate the accuracy of the proposed method on parameter estimation, and (2) those based on mimicking the motivating data set to examine the robustness of the proposed method. Finally, the proposed method is applied to real data with detailed discussion of the results and comparisons with other methods.
Data
Qian et al. (Qian F. et al.: Identification of genes critical for resistance to infection by West Nile virus using RNA-Seq analysis, submitted) designed an RNA-Seq experiment to study human West Nile virus (WNV) infection. One objective of this study was to identify altered genes/transcripts from viral infection of primary human macrophages in comparison to uninfected samples. This study naturally has a paired design structure. A total of 10 healthy donors were recruited according to the guidelines of the human research protection program of Yale University and cells were isolated from fresh heparinized blood samples for infection with WNV (strain CT 2741, MOI=1, for 24 hours) as described previously [39]. PolyA+ RNA was prepared from uninfected and WNV-infected primary macrophages, fragmented, and subjected to sequencing using the Illumina Genome Analyzer 2. Approximately 50 million quality filtered reads were obtained from each sample, and about 85% were mapped to the human transcriptome (hg19) with ENSEMBL transcript annotations (Release 57) using TOPHAT v.1.1.4 [40]. Genes and transcript isoforms were scored for expression by a maximum likelihood based method implemented in Cufflinks v.0.9.3 [41]. To analyze differential expression, the data were first converted from the FPKM unit (fragments per kilobase of exon per million fragments mapped) to the number of reads originated from each transcript isoform. The trimmed-mean method [42] was applied to further normalize the count expression values. The processed data contains transcript-level expression counts from a total of 20 samples consisting of 10 pairs of uninfected and virus infected samples. For differential expression analysis, we removed transcripts with less than 10 total counts across 10 uninfected samples or no observed count from 6 or more individuals in the uninfected conditions. After these steps, 37,111 transcripts were considered for data analysis.
Methods
Bayesian mixture model for paired counts
This model allows us to obtain a simpler form of the predictive density, i.e., the λ_{ g i }’s can be integrated out (see Appendix).
- 1.
(Π _{0}, Π _{1})∼ Dirichlet(1,1), i.e., Π _{0} ∼ Uniform(0, 1).
- 2.
Each α _{ g }and β _{ g }has a non-informative prior.
- 3.
$p\left({\sigma}_{0}^{2}\right)\propto 1/{\sigma}_{0}^{2}$ and $p\left({\sigma}_{1}^{2}\right)\propto 1/{\sigma}_{1}^{2}$.
- 4.
μ _{1} has an improper prior.
- 5.
Joint independency among all the parameters.
Parameter estimation via Markov chain Monte-Carlo (MCMC)
In this section, we describe the Gibbs sampling algorithm [43] that we use to iteratively sample model parameters from their conditional distributions given the other parameters and the observed data. First, we evaluate the conditional distribution of parameters (α_{ g }, β_{ g }) characterizing the baseline expression distribution (λ_{ gi }). These parameters are separately updated using the Metropolis-Hastings algorithm. For the latent state z_{ g }and expression level change χ_{ g }, the state z_{ g }is first proposed and then χ_{ g }is sampled given the state. Lewin et al. [38] discussed this type of move with various choices of the mixture distribution. Details of our updates on the pair of (χ_{ g }, z_{ g }) are described in the Appendix. Mixing proportions (Π_{0}, Π_{1}) and hyper-parameters for the mixture distribution (${\sigma}_{0}^{2}$, ${\sigma}_{1}^{2}$, μ_{1}) are sampled from their conditional posterior distributions which can be derived in closed forms.
DE classification and false discovery rate estimation
The method was implemented in R and is available at http://bioinformatics.med.yale.edu.
Results and discussion
Simulations
Simulations based on the model assumptions
The first part of the simulation was conducted to examine the performance of the proposed approach when the data are generated under the model assumptions. For 10,000 genes and 10 individuals, we simulate expression counts both before and after treatment according to Equation 1. Library sizes are sampled uniformly from 7 to 18 millions and relative expected baseline expression λ_{ g i }are drawn from a Gamma distribution with shape 0.1 and rate 1,000. For simplicity, we consider a two-component log-normal mixture model for effect size. For the null genes (90%), the log-scaled effect is sampled from a normal distribution with a mean 0 and a standard deviation (σ_{0}) 0.1, whereas the log-effects are sampled from a normal distribution with mean (μ_{1}) of 1.5 and standard deviation (σ_{1}) of 0.5 for the non-null genes. For the simulation studies, the true library sizes are used for the parameter estimation.
Posterior means of the parameters in the model
Parameters | True parameter | Posterior mean |
---|---|---|
${\sigma}_{0}^{2}$ | 0.01 | 0.013 (0.002) |
μ _{1} | 1.5 | 1.501 (0.015) |
${\sigma}_{1}^{2}$ | 0.25 | 0.238 (0.015) |
Π _{1} | 0.1 | 0.099 (0.001) |
Simulations based on the empirical data
In the second part of the simulation, we assume that the expression abundance is measured for 5,000 genes simultaneously before and after a given treatment. The number of individuals is set to be 10 for the relatively larger sample case (cases 1 and 4), 5 for the medium (cases 2 and 5), and 3 for the relatively smaller sample case (cases 3 and 6). The size of each library is randomly sampled from 1.8 to 3 million to have simulated count distribution compatible with the real data distribution. The infected set of the RNA-seq data (Data Section, Qian F. et al. for details) was used as the expected baseline count data to mimic the observed mean-specific dispersion. First, we sample 5,000 gene indices with replacement to get the expected baseline expression. Expression counts from the selected indices are summarized by a matrix where rows from this data matrix correspond to the selected genes in the original data matrix and columns correspond to individuals. Then, the relative expression (λ_{gi, i = 1, …, N}, Equation 1) is computed proportional to the total counts in each sample.
Among 5,000 genes, the first 4,000 are assumed to have no change (z_{ g } = 0) and their log-fold changes, log(χ_{ g }), are sampled from a normal distribution with a mean of 0 and a variance of 4 × 10^{-4}. For the rest of non-null genes, we considered the following two scenarios. An empirical set-up (cases 1, 2, 3) utilizes nominal fold change from the uninfected data set. Cases 4, 5, and 6 consider a theoretical setup, where the log-scaled fold change is drawn from a normal distribution with a mean of zero and a variance of 1. We further filter out non-null genes whose true fold changes are less than 1.4.
Each case was repeated 100 times. We compare the performance of our approach with DESeq (version 1.8.3) [22] and edgeR (version 2.6.10) [21], two widely used methods for RNA-seq data for the purpose of identifying differentially expressed genes. These two methods assume a negative binomial distribution to explain the variance due to the replicate. DESeq utilizes a smoothing curve to compute the overdispersion as a function of the average expression level. An option ‘pooled-CR’ is used to estimate the overdispersion parameter [44]. In edgeR, a common dispersion setting is used which assumes a consistent overdispersion across all the features and estimates the parameter using a common likelihood function. A paired design can be incorporated by utilizing generalized linear model. For each application, the true library sizes are used as the library size inputs.
Estimated posterior means and results for empirical simulation
Case 1 | Case 2 | Case 3 | |
---|---|---|---|
N | 10 | 5 | 3 |
μ _{1} | -0.170 (0.037) | -0.169 (0.041) | -0.157 (0.041) |
${\sigma}_{0}^{2}$ | 3.653×10^{-4} | 3.604×10^{-4} | 3.83×10^{-4} |
(3×10^{-5}) | (4.421×10^{-5}) | (6.090×10^{-5}) | |
${\sigma}_{1}^{2}$ | 0.984 (0.104) | 0.968 (0.115) | 0.955 (0.110) |
Π _{1} | 0.151 (0.004) | 0.153 (0.005) | 0.156 (0.006) |
$\mathit{\text{cor}}{({\chi}_{g},\hat{{\chi}_{g}})}^{\ast}$ | 0.972 (0.006) | 0.993 (0.003) | 0.953 (0.011) |
FDR | 0.030 (0.008) | 0.046 (0.011) | 0.068 (0.013) |
$\hat{\mathit{\text{FDR}}}$ | 0.024 (0.004) | 0.037 (0.005) | 0.049 (0.006) |
Sensitivity | 0.928 (0.014) | 0.866 (0.020) | 0.802 (0.025) |
Specificity | 0.995 (0.001) | 0.994 (0.002) | 0.991 (0.002) |
Case 4 | Case 5 | Case 6 | |
N | 10 | 5 | 3 |
μ _{1} | 0.007 (0.035) | 0.006 (0.038) | -0.002 (0.037) |
${\sigma}_{0}^{2}$ | 3.634×10^{-4} | 3.532×10^{-4} | 3.450×10^{-4} |
(2.931×10^{-5}) | (4.155×10^{-5}) | (5.283×10^{-5}) | |
${\sigma}_{1}^{2}$ | 1.172 (0.048) | 1.151 (0.059) | 1.140 (0.050) |
Π _{1} | 0.179 (0.003) | 0.183 (0.004) | 0.188 (0.005) |
$\mathit{\text{cor}}{({\chi}_{g},\hat{{\chi}_{g}})}^{\ast}$ | 0.990 (0.002) | 0.979 (0.004) | 0.965 (0.007) |
FDR | 0.030 (0.008) | 0.044 (0.009) | 0.064 (0.012) |
$\hat{\mathit{\text{FDR}}}$ | 0.021 (0.004) | 0.031 (0.005) | 0.042 (0.006) |
Sensitivity | 0.953 (0.011) | 0.906 (0.015) | 0.862 (0.020) |
Specificity | 0.995 (0.001) | 0.992 (0.002) | 0.989 (0.002) |
We further considered a simulation scenario similar with the real data. As shown in the data application, the log-scaled fold change estimated from the data has larger variance under null component. We set the null component variance to be 0.35 and repeated the simulation 50 times. For features in the non-null group, log-fold change was sampled from a normal distribution with a mean of -0.45 and a variance of 4. Simulation was performed with the sample size of 10 (case 7) and the size of 5 (case 8). Averages of the parameter estimates $({\mu}_{1},{\sigma}_{0}^{2},{\sigma}_{1}^{2},{\Pi}_{1})$ for cases 7 and 8 are (-0.42, 0.35, 3.92, 0.20) and (-0.42, 0.35, 3.85, 0.21), respectively. Similarly with the cases 1 through 6, the estimated false discovery rate is examined (Figure 3) and performance of the proposed approach is compared with two existing methods (Figure 4).
Applications
Differential expression analysis with the Bayesian modeling
Comparisons with existing methods
Bioinformatics annotations of the results
Selected pathways from the functional analysis
Term | Count | p-value | |
---|---|---|---|
Cluster 1 | score: 11.39 | ||
Defense response | GO:0006952 | 106 | 5.3E-14 |
Response to wonding | GO:0006954 | 90 | 1.3E-11 |
Inflammatory response | GO:0009611 | 63 | 1.0E-10 |
Cluster 2 | score: 5.43 | ||
Response to molecule of lipopolysaccharide | GO:0002237 | 23 | 9.4E-8 |
Response to cytokine stimulus | GO:0034097 | 18 | 8.0E-5 |
Response to bacterium | GO:0009617 | 31 | 3.5E-4 |
Cluster 3 | score: 5.19 | ||
Regulation of cytokine production | GO:0001817 | 41 | 2.9E-9 |
Positive regulation of cytokine production | GO:0001819 | 20 | 8.0E-5 |
positive regulation of multicellular organismal process | GO:0051240 | 35 | 1.1E-3 |
Cluster 8 | score: 2.89 | ||
Regulation of apoptosis | GO:0042981 | 100 | 1.0E-5 |
Regulation of programmed cell death | GO:0043067 | 100 | 1.5E-5 |
Regulation of cell death | GO:0010941 | 100 | 1.8E-5 |
Cluster 10 | score: 2.72 | ||
Leukocyte activation | GO:0045321 | 41 | 9.2E-6 |
Cell activation | GO:0001775 | 46 | 1.1E-5 |
T cell activation | GO:0046649 | 26 | 2.0E-5 |
Conclusions
In this paper, we have presented a hierarchical mixture model for the identification of differential gene expression from RNA-Seq data motivated by a West Nile Virus study, which collected samples as multiple pairs, i.e. pre- vs. post-treatment for each individual. While such design is common in biological investigations, few existing methods analyze such data appropriately. With a hierarchical Bayesian mixture model coupled with inference through MCMC, our approach incorporates variability across genes, individuals, and treatment effects in the context of a paired experiment. Application to both simulated and real data demonstrates that our model and implementation is suitable for paired design, having distinct advantages compared to the existing methods.
Simulation study suggests that our Bayesian setting can have better power to detect differential gene expression. In the real data application, our proposed is able to identify transcripts with large treatment effects but low expression levels, whereas these transcripts were not inferred to be differentially expressed by other approaches. This is likely due to the more flexible and adaptable modeling of variance across individuals in our approach. Further examination of the characteristics of these top-ranked transcripts shows that the proportion of top-ranked transcripts in the short transcript group is consistent with the proportion in the long transcript group. On the other hand, the gene sets detected by the existing approaches show a bias towards longer transcripts, as has been noted in the literature before [48, 49]. Our model reduces this bias and as a result facilitates detection of some short-length differentially expressed transcripts that the other approaches miss.
We have assumed that the log-fold change arises from a mixture of two normal distributions. Under DE, the model allows the mean of log-fold change distribution not to be restricted at zero. By doing so, our proposed model can be applied to the data showing asymmetry between over and under expression. A normal distributional assumption is shown to be robust from simulation study under empirical fold change scenarios. Other possible choices for the null genes include a point mass at 0 [50], uniform distribution around 0, and a log-Gamma distribution with a mean 0. Similar distributional assumptions can be made for the non-null genes under the two-component mixture set-up. Alternatively, one can consider a mixture of three components consisting of equal, over, and under expression states. Further extension can be considered by allowing variation in the magnitude of expression change across individuals.
Appendix
Variability across individuals
Modeling details
We use the non-informative prior distributions for the unknown model parameters specified in the Methods Section.
Parameter estimates by the Metropolis-Hastings algorithm (MCMC)
We infer the posterior distributions using the Gibbs sampling [43], which iteratively samples model paramters from the conditional distribution of each patermter given the other parameters. In this section, we describe the procedure for the posterior inference.
Step1
If the proposal is accepted, we replace the old α_{ g } with the new one. Otherwise, α_{ g } stays at the current value.
Step2
Similarly, θ_{ - }β_{ g } is the vector of parameters except β_{ g }. For the evaluation of the acceptance probability, updated value of α_{ g } in the Step 1 will be used.
Step3
Update (χ_{ g }, z_{ g }) by utilizing generalized Metropolis-Hastings. Lewin et al. [38] pointed out that χ_{ g } and z_{ g } have to be jointly estimated since the supporting space of χ_{ g } depends on the choice of z_{ g }. For example, χ_{ g } is a point mass at one if z_{ g } = 0. To estimate a pair of (χ_{ g }, z_{ g }), they proposed the state z_{ g } first and then updated χ_{ g }|z_{ g }. By utilizing this approach, we adopt the following steps to sample (χ_{ g }, z_{ g }).
(Step 3-1) Generate ${z}_{g}^{\mathit{\text{new}}}$ from the Bernoulli distribution, with $P({z}_{g}^{\mathit{\text{new}}}=0)={\Pi}_{0}^{\mathit{\text{old}}}$.
(Step 3-2) Then, ${\chi}_{g}^{\mathit{\text{new}}}$ is proposed from LogNormal(0, V_{ g }) if ${z}_{g}^{\mathit{\text{new}}}=0$. Otherwise, it is sampled from LogNormal(M_{ g }, V_{ g }). The mean and variance of the log-normal proposal distribution are computed from the observed counts. First, we collect individuals whose pre- and post-treatment counts are non-zero for each gene, separately. Then, M_{ g } is computed as a median of $log\left(\frac{{y}_{\mathit{\text{gi}}1}}{{N}_{i1}}/\frac{{y}_{\mathit{\text{gi}}2}}{{N}_{i2}}\right)$ for such individuals. The variance of these values can be used as V_{ g }, however, this estimate often gives an extreme value. In data analysis, we trim the estimates at 25th and 75th percentiles when the sample size is 10. For small sample case, the median of V_{ g }’s is used as the proposal variance.
Alternative description
where $t\left({\chi}_{g}\right)=\prod _{i}\frac{{\chi}_{g}^{{y}_{\mathit{\text{gi}}2}}}{{({\beta}_{g}+{N}_{i1}+{\chi}_{g}{N}_{i2})}^{{y}_{\mathit{\text{gi}}1}+{y}_{\mathit{\text{gi}}2}+{\alpha}_{g}}}$, LN_{0} is a probability density function for log-normal distribution with mean zero and variance ${\sigma}_{0}^{2,\mathit{\text{old}}}$. Similarly, LN_{1} is a log-normal density centered at ${\mu}_{1}^{\mathit{\text{new}}}$ and variance ${\sigma}_{1}^{2,\mathit{\text{old}}}$.
Step4
where $\u266f({z}_{g}=0)=\sum _{g}I({z}_{g}=0)$ and $\u266f({z}_{g}=1)=\sum _{g}I({z}_{g}=1)$.
Step5
Update the mixing proportions (Π_{0}, Π_{1}). We assume a Dirichilet prior for the mixture probabilities. Using Gibbs sampling scheme, these weight parameters are updated from Dir(1 + ♯(z_{ g } = 0), 1 + ♯(z_{ g } = s1)).
Declarations
Acknowledgements
This work was supported in part by Grant GM59507 from NIH, 5T15LM007056-25 from PHS/DHHS, UL1 RR024139 from Yale CTSA grant, and awards from the NIH (HHS N272201100019C, AI 070343, AI 089992).
Authors’ Affiliations
References
- Velculescu V, Zhang L, Vogelstein B, Kinzler K: Serial analysis of gene expression. Science. 1995, 270: 484-487. 10.1126/science.270.5235.484.View ArticlePubMed
- Margulies M, Egholm M, Altman W, Attiya S, Bader J, Bemben L, Berka J, Braverman M, Chen Y: Genome sequencing in microfabricated high-density picolitre reactors. Nature. 2005, 437: 376-380.PubMed CentralPubMed
- Bennett S, Barnes C, Cox A, Davies L, Brown C: Toward the 1,000 dollars human genome. Pharmacogenomics. 2005, 6: 373-382. 10.1517/14622416.6.4.373.View ArticlePubMed
- ‘t Hoen P, Ariyurek Y, Thygesen H, Vreugdenhil E, Vossen R, de Menezes R, Boer G, van Ommen G, den Dunnen J: Deep sequencing-based expression analysis shows major advances in robustness, resolution and inter-lab portability over five microarray platforms. Nucleic Acids Res. 2008, 36: e141-10.1093/nar/gkn705.PubMed CentralView ArticlePubMed
- Wang GMZ, Snyder M: RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 2009, 10: 57-63. 10.1038/nrg2484.PubMed CentralView ArticlePubMed
- Marioni J, Mason C, Mane S, Stephens M, Gilad Y: RNA-seq: An assessment of technical reproducibility and comparison with gene expression arrays. Genome Res. 2008, 18: 1509-1519. 10.1101/gr.079558.108.PubMed CentralView ArticlePubMed
- Mortazavi A, Williams B, McCue K, Schaeffer L, Wold B: Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods. 2008, 5: 621-628. 10.1038/nmeth.1226.View ArticlePubMed
- Miller N, Kingsmore S, Farmer A, Langley R, Mudge J, Crow J, Gonzalez A, Schilkey F, Kim R, van Velkinburgh J, May G, Black C, Myers M, Utsey J, Frost N, Sugarbaker D, Bueno R, Gullans S, Baxter S, Day S, Retzel E: Management of high-throughput DNA sequencing projects: Alpheus. J Comput Sci Syst Biol. 2008, 1: 132-148. 10.4172/jcsb.1000013.PubMed CentralPubMed
- Fu X, Fu N, Guo S, Yan Z, Xu Y, Hu H, Menzel C, Chen W, Li Y, Zeng R, Khaitovich P: Estimating accuracy of RNA-Seq and microarrays with proteomics. BMC Genomics. 2009, 10: 161-10.1186/1471-2164-10-161.PubMed CentralView ArticlePubMed
- Audic S, Claverie J: The significance of digital gene expression profiles. Genome Res. 1997, 7: 986-995.PubMed
- Madden S, Galella E, Zhu J, Bertelsen A, Beaudry G: SAGE transcript profiles for p53-dependent growth regulation. Oncogene. 1997, 15: 1079-1085. 10.1038/sj.onc.1201091.View ArticlePubMed
- Kal A, van Zonneveld A, Benes V, van den Berg M, Koerkamp M, Albermann K, Strack N, Ruijter J, Richter A, Dujon B, Ansorge B, Tabak H: Dynamics of gene expression revealed by comparison of serial analysis of gene expression transcript profiles from yeast grown on two different carbon sources. Mol Biol Cell. 1999, 10: 1859-1872.PubMed CentralView ArticlePubMed
- Bullard JH, Purdom E, Hansen KD, Dudoit S: Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments. BMC Bioinformatics. 2010, 11: 94-10.1186/1471-2105-11-94.PubMed CentralView ArticlePubMed
- Li WDJIJ, Tibshirani R: Normalizing, testing, and false discovery rate estimation for RNA-sequencing data. Biostatistics. 2012, 13: 523-538. 10.1093/biostatistics/kxr031.PubMed CentralView ArticlePubMed
- Baggerly K, Deng L, Morris J, Marcelo Aldaz C: Differential expression in SAGE: accounting for normal between-library variation. Bioinformatics. 2003, 19: 1477-1483. 10.1093/bioinformatics/btg173.View ArticlePubMed
- Zhou XKY, Wright F: A Powerful and flexible approach to the analysis of RNA sequence count data. Bioinformatics. 2011, 27: 2672-2678. 10.1093/bioinformatics/btr449.PubMed CentralView ArticlePubMed
- Baggerly K, Deng L, Morris J, Marcelo Aldaz C: Overdispersed logistic regression for SAGE: modelling multiple groups and covariates. BMC Bioinformatics. 2004, 5: 144-10.1186/1471-2105-5-144.PubMed CentralView ArticlePubMed
- Lu J, Tomfohr J, Kepler T: Identifying differential expression in multiple SAGE libraries: an overdispersed log-linear model approach. Bioinformatics. 2005, 6: 165-PubMed CentralPubMed
- Robinson M, Smyth G: Moderated statistical tests for assessing differences in tag abundance. Bioinformatics. 2007, 23: 2881-2887. 10.1093/bioinformatics/btm453.View ArticlePubMed
- Robinson M, Smyth G: Small sample estimation of negative binomial dispersion, with applications to SAGE data. Biostatistics. 2008, 9: 321-332.View ArticlePubMed
- McCarthy D, Chen Y, Smyth G: Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 2012, Epub
- Anders S, Huber W: Differential expression analysis for sequence count data. Genome Biol. 2010, 11: R106-10.1186/gb-2010-11-10-r106.PubMed CentralView ArticlePubMed
- Hardcastle T, Kelly K: baySeq: Empirical Bayesian methods for identifying differential expression in sequence count data. BMC Bioinformatics. 2010, 11: 422-10.1186/1471-2105-11-422.PubMed CentralView ArticlePubMed
- Vencio RZ, Brentani H, Patrao DF, Pereira CA: Bayesian model accounting for within-class biological variability in Serial Analysis of Gene Expression (SAGE). BMC Bioinformatics. 2004, 31: 119-View Article
- Zuyderduyn S: Statitical analyis and significance testing of serial analysis of gene expression data using a Poisson mixture model. BMC Bioinformatics. 2007, 8: 282-10.1186/1471-2105-8-282.PubMed CentralView ArticlePubMed
- Li J, Tibshirani R: Finding consistent patterns: A nonparametric approach for identifying differential expression in RNA-Seq data. Stat Methods Med Res. 2011, Epub November 28, 2011 http://www.ncbi.nlm.nih.gov/pubmed/22127579
- Farewell VT, Sprott DA: The use of a mixture model in the analysis of count data. Biometrics. 1988, 44: 1191-1194. 10.2307/2531746.View ArticlePubMed
- Lee HS: Analysis of overdispersed paired count data. Canadian J Stat. 1996, 24: 319-326. 10.2307/3315742.View Article
- Karlis D, Ntzoufras I: Bayesian analysis of the differences of count data. Stat Med. 2006, 25: 1885-1905. 10.1002/sim.2382.View ArticlePubMed
- Khafrim S, Kazemnejad A, Eskandari F: Hierarchical Bayesian analysis of bivariate poisson regression model. World Appl Sci J. 2008, 4: 667-675.
- Newton MA, Noueiry A, Sarkar D, Ahlquist P: Detecting differential gene expression with a semiparametric hierarchical mixture method. Biostat. 2004, 5 (2): 155-176. 10.1093/biostatistics/5.2.155.View Article
- Newton MA, Kendziorski CM, Richmond CS, Blattner FR, Tsui KW: On differential variability of expression ratios: improving statistical inference about gene expression changes from microarray data. J Comput Biol. 2001, 8: 37-52. 10.1089/106652701300099074.View ArticlePubMed
- Kendziorski CM, Newton MA, Lan H, Gould M: On parametric empirical bayes methods for comparing multiple groups using replicated gene expression profiles. Stat Med. 2003, 22: 3899-3914. 10.1002/sim.1548.View ArticlePubMed
- Smyth GK: Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004, 3: 3-
- Loennstedt I, Britton T: Hierarchical Bayes models for cDNA microarray gene expression. Biostatistics. 2005, 6: 279-291. 10.1093/biostatistics/kxi009.View Article
- Gottardo R, Raftery AE, Yeung KY, Bumgarner RE: Bayesian robust inference for differential gene expression in microarrays with multiple Samples. Biometrics. 2006, 62: 10-18.View ArticlePubMed
- Do K, Mueller P, Tang F: A Bayesian mixture model for differential gene expression. Appl Stat. 2005, 54: 627-644.
- Lewin A, Bochkina N, Richardson S: Fully Bayesian mixture model for differential gene expression: simulations and model checks. Stat Appl Genet Mol Biol. 2007, 6: 36-
- Kong K, Delroux K, Wang X, Qian F, Arjona A, Malawista S, Fikrig E, Montgomery R: Dysregulation of TLR3 impairs the innate immune response to west Nile virus in the elderly. J Virol. 2008, 82: 7613-7623. 10.1128/JVI.00618-08.PubMed CentralView ArticlePubMed
- Trapnell C, Pachter L, Salzberg S: TopHat: discovering splice junctions with RNA-Seq. Bioinformatics. 2009, 25: 1105-1111. 10.1093/bioinformatics/btp120.PubMed CentralView ArticlePubMed
- Trapnell C, Williams B, Pertea G, Mortazavi A, Kwan G, van Baren M, Salzberg S, Wold B, Pachter L: Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Biotechnol. 2010, 28: 511-515. 10.1038/nbt.1621.
- Robinson M, Oshlack A: A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010, 11: R25-10.1186/gb-2010-11-3-r25.PubMed CentralView ArticlePubMed
- Geman S, Geman D: Stochastic relaxation, Gibbs distributions, and the Bayesian restoration of images. IEEE Trans Pattern Anal Mach Intell. 1984, 6: 721-741.View ArticlePubMed
- Anders S, Huber W: Differential expression of RNA-Seq data at the gene level - the DESeq package. 2013, [http://www.bioconductor.org/packages/devel/bioc/vignettes/DESeq/inst/doc/DESeq.pdf]
- Bouchon CMGHCJA, Colonna M: Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family. J Immunol. 2001, 167: 5517-5521.View ArticlePubMed
- Parquet M, Kumatori A, Hasebe F, Morita K, Igarashi A: West Nile virus-induced bax-dependent apoptosis. FEBS letters. 2001, 500: 17-24. 10.1016/S0014-5793(01)02573-X.View ArticlePubMed
- Medigeshi G, Lancaster A, Hirsch A, Briese T, Lipkin W, DeFilippis V, Frueh K, Mason P, Nikolich-Zugich J, Nelson J: West Nile virus infection activates the unfolded protein response, leading to CHOP induction and apoptosis. J Virol. 2007, 81: 10849-10860. 10.1128/JVI.01151-07.PubMed CentralView ArticlePubMed
- Oshlack A, Wakefield M: Transcript length bias in RNA-seq data confounds systems biology. Biol Direct. 2009, 4: 14-10.1186/1745-6150-4-14.PubMed CentralView ArticlePubMed
- Zheng W, Chung L, Zhao H: Bias detection and correction in RNA-Sequencing data. BMC Bioinformatics. 2011, 12: 290-10.1186/1471-2105-12-290.PubMed CentralView ArticlePubMed
- Gottardo R, Raftery A: Markov chain Monte Carlo computations with mixture of singular distributions. Technical Report 470, Statistics Department. Seattle: University of Washington; 2004
Copyright
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.